Robert Flisiak
Impact in
- Hepatology top 0.02%
- Hepatitis C virus research
- Hepatitis Viruses Studies and Epidemiology
- Liver Disease and Transplantation
- Epidemiology top 0.1%
- Hepatitis B Virus Studies
- Liver Disease Diagnosis and Treatment
Papers in
- Hepatology 221
- Hepatitis C virus research 200
- Liver Disease and Transplantation 15
- Epidemiology 176
- Hepatitis B Virus Studies 116
- Liver Disease Diagnosis and Treatment 101
- Co-authors
- Jerzy Jaroszewicz (88 shared papers)Patrick Marcellin (18 shared papers)Danuta Prokopowicz (30 shared papers)Anna Parfieniuk‐Kowerda (51 shared papers)Dorota Zarębska‐Michaluk (98 shared papers)Edward John Gane (6 shared papers)Thomas Berg (6 shared papers)Michael Fried (2 shared papers)
- Journals
- Journal of Hepatology (54 papers)Journal of Clinical Medicine (22 papers)Journal of Viral Hepatitis (16 papers)World Journal of Gastroenterology (12 papers)Liver International (12 papers)
- Partner nations
- PolandUnited StatesGermany
In The Last Decade
Robert Flisiak
411 papers receiving 16.9k citations
Robert Flisiak's Hit Papers
Peers
Comparison fields: 5 of 157
- Hepatology 11.1k
- Epidemiology 9.9k
- Infectious Diseases 2.2k
- Virology 279
- Immunology 662
Countries citing papers authored by Robert Flisiak
This map shows the geographic impact of Robert Flisiak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Flisiak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Flisiak more than expected).
Fields of papers citing papers by Robert Flisiak
This network shows the impact of papers produced by Robert Flisiak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Flisiak. The network helps show where Robert Flisiak may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Flisiak, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 433 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection Hit paper breakdown → | 2011 | 1982 |
| 2 | Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study Hit paper breakdown → | 2016 | 1652 |
| 3 | Peginterferon Alfa-2a, Lamivudine, and the Combination for HBeAg-Positive Chronic Hepatitis B Hit paper breakdown → | 2005 | 1253 |
| 4 | Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis B Hit paper breakdown → | 2008 | 968 |
| 5 | Sofosbuvir and Ribavirin in HCV Genotypes 2 and 3 Hit paper breakdown → | 2014 | 668 |
| 6 | Advancing the global public health agenda for NAFLD: a consensus statement Hit paper breakdown → | 2021 | 600 |
| 7 | Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study Hit paper breakdown → | 2022 | 479 |
| 8 | 2010 | 399 | |
| 9 | 2010 | 351 | |
| 10 | Glecaprevir–Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection Hit paper breakdown → | 2018 | 340 |
| 11 | 2011 | 337 | |
| 12 | 2015 | 292 | |
| 13 | 2013 | 242 | |
| 14 | 2015 | 242 | |
| 15 | 2014 | 238 | |
| 16 | 2010 | 196 | |
| 17 | 2008 | 191 | |
| 18 | 2009 | 184 | |
| 19 | 2014 | 130 | |
| 20 | 2017 | 127 |
About Robert Flisiak
Robert Flisiak is a scholar working on Hepatology, Epidemiology, Infectious Diseases, Neurology and Genetics, having authored 433 papers that have together received 17.5k indexed citations. Recurring topics across this work include Hepatitis C virus research (200 papers), Hepatitis B Virus Studies (116 papers), Liver Disease Diagnosis and Treatment (101 papers), COVID-19 Clinical Research Studies (35 papers), SARS-CoV-2 and COVID-19 Research (30 papers), Long-Term Effects of COVID-19 (17 papers), HIV/AIDS drug development and treatment (17 papers) and Liver Disease and Transplantation (15 papers). The work is most often cited by research in Hepatology (11.1k citations), Epidemiology (9.9k citations), Infectious Diseases (2.2k citations), Virology (279 citations) and Immunology (662 citations). Robert Flisiak has collaborated with scholars based in Poland, United States and Germany. Frequent co-authors include Jerzy Jaroszewicz, Patrick Marcellin, Danuta Prokopowicz, Anna Parfieniuk‐Kowerda, Dorota Zarębska‐Michaluk, Edward John Gane, Thomas Berg, Michael Fried, Teerha Piratvisuth and Małgorzata Pawłowska. Their work appears in journals such as Journal of Hepatology, Journal of Clinical Medicine, Journal of Viral Hepatitis, World Journal of Gastroenterology and Liver International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.